rethinkPeptides Search
Menu
Research citation

Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.

European journal of pharmacology, 811, 30-37

Citation

Yoshimura, Makoto; Shiomi, Yoshihiro; Ohira, Yuta; Takei, Mineo; Tanaka, Takao. (2017). Z-505 hydrochloride, an orally active ghrelin agonist, attenuates the progression of cancer cachexia via anabolic hormones in Colon 26 tumor-bearing mice.. European journal of pharmacology, 811, 30-37. https://doi.org/10.1016/j.ejphar.2017.05.036